NYSE$TDOC
Teladoc Health Inc · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Teladoc Health's revenue increased, and net loss decreased significantly compared to the previous year.
Teladoc Health reported a 4% increase in revenue for Q4 2023, reaching $660.5 million. The net loss was $28.9 million, a significant improvement from the $3,810.1 million loss in Q4 2022. Adjusted EBITDA increased by 22% to $114.4 million. The company provided financial guidance for Q1 2024 and the full year 2024.
- Q4 2023 revenue increased by 4% year-over-year to $660.5 million.
- Net loss for Q4 2023 was $28.9 million, a substantial improvement from the $3,810.1 million loss in Q4 2022.
- Adjusted EBITDA for Q4 2023 increased by 22% to $114.4 million.
- The company initiates 2024 guidance, projecting revenue between $2.635 and $2.735 billion and adjusted EBITDA between $350 and $390 million.
Headline financials
Revenue & EPS history
Teladoc · Revenue · Quarterly
$661M
Revenue by segment
Teladoc · $660M total across 2 segments · Q3 2023
- Integrated Care$374M—56.7%
- BetterHelp$286M—43.3%
Forward guidance
Teladoc Health provided financial guidance for the first quarter and full year of 2024.
Tailwinds
- Revenue: $630 - $645 million (Q1 2024)
- Revenue: $2,635 - $2,735 million (Full Year 2024)
- Adjusted EBITDA: $52 - $62 million (Q1 2024)
- Adjusted EBITDA: $350 - $390 million (Full Year 2024)
- Free Cash Flow: $210 - $240 million (Full Year 2024)
Headwinds
- Net loss per share: ($0.55) - ($0.45) (Q1 2024)
- Net loss per share: ($1.10) - ($0.80) (Full Year 2024)
- BetterHelp Revenue growth percentage (year-over-year): (6%) - (3%) (Q1 2024)
- Integrated CareRevenue growth percentage (year-over-year)5% - 7% (Q1 2024)
- BetterHelpRevenue growth percentage (year-over-year)Flat to low-single-digits (Full Year 2024)
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
-1.2%
Avg return
Earnings day
-2.1%
Avg return
5 days after
-1.6%
Avg return
30 days after
49%
21 / 43 earnings
Positive
+23.7%
Q2 2023
Best reaction
-42.0%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.8% | +11.9% | +27.9% | |
| Q4 2025 | +15.5% | +9.7% | +10.5% | |
| Q3 2025 | +6.2% | -3.0% | -7.8% | |
| Q1 2025 | -2.8% | -5.7% | -3.8% | |
| Q4 2024 | -13.6% | -16.3% | -26.4% | |
| Q3 2024 | +0.9% | -0.6% | +34.3% | |
| Q2 2024 | -11.7% | -21.9% | -26.3% | |
| Q1 2024 | -5.2% | -7.1% | -16.4% | |
| Q4 2023 | -25.6% | -31.1% | -27.3% | |
| Q3 2023 | -3.3% | -13.5% | -5.3% | |
| Q2 2023 | +23.7% | +20.9% | -6.1% | |
| Q1 2023 | +3.4% | +2.2% | -14.4% | |
| Q4 2022 | -3.9% | -5.4% | -12.2% | |
| Q3 2022 | +6.4% | +10.8% | +3.2% | |
| Q2 2022 | -11.4% | -8.4% | -20.1% | |
| Q1 2022 | -42.0% | -35.7% | -38.1% | |
| Q4 2021 | -5.4% | +8.8% | +6.8% | |
| Q3 2021 | +5.6% | +7.2% | -22.4% | |
| Q2 2021 | +1.4% | -0.9% | -5.5% | |
| Q1 2021 | -10.1% | -14.1% | -20.7% | |
| Q4 2020 | -14.2% | -12.7% | -30.9% | |
| Q3 2020 | -2.3% | -14.6% | -11.9% | |
| Q2 2020 | +11.5% | +11.5% | -1.9% | |
| Q1 2020 | -9.1% | -3.8% | -3.9% | |
| Q4 2019 | +14.1% | +5.1% | +38.6% | |
| Q3 2019 | +7.1% | +12.3% | +17.1% | |
| Q2 2019 | +1.9% | -6.5% | -17.5% | |
| Q1 2019 | -2.0% | +2.9% | -1.8% | |
| Q4 2018 | -4.5% | -6.3% | -17.5% | |
| Q3 2018 | +4.6% | -8.6% | -9.9% | |
| Q2 2018 | +9.0% | +10.3% | +29.6% | |
| Q1 2018 | +5.7% | -1.9% | +18.4% | |
| Q4 2017 | +4.0% | +8.8% | +4.5% | |
| Q3 2017 | -3.0% | -5.4% | +8.0% | |
| Q2 2017 | -7.1% | -2.6% | +5.5% | |
| Q1 2017 | +23.3% | +26.9% | +46.3% | |
| Q4 2016 | +6.8% | -4.8% | +13.4% | |
| Q3 2016 | +6.2% | +8.6% | +19.4% | |
| Q2 2016 | -16.1% | -9.0% | +2.9% | |
| Q1 2016 | -1.5% | — | — | |
| Q4 2015 | -7.3% | — | — | |
| Q3 2015 | -10.6% | — | — | |
| Q2 2015 | +3.6% | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro